Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG '4-Nov) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/'4-Nov/by-state?code_type=APR_DRG
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG '4-Nov) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/'4-Nov/by-state?code_type=APR_DRG. Accessed
June 30, 2026 .
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG '4-Nov) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/'4-Nov/by-state?code_type=APR_DRG.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
APR-DRG · across United States
'4-Nov — Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$236,258
National median
$236,258 – $236,258
IQR (p25 – p75)
3
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for '4-Nov (APR_DRG), with interquartile range
State Median p25 p75
CT $236,258 $236,258 $236,258